GlassScriptPhysician profile
Chester S Klimek
NPI 1003294950
$8,288.38
in general payments reported to CMS, 2019-2025
16 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,309 · 2020: $53.34 · 2021: $300 · 2022: $438 · 2023: $1,026 · 2024: $722 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,617 · Travel and Lodging: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.85 |
| Travel and Lodging | $571.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,853.00 | 2019 | |
| Stryker Corporation | $1,794.70 | 2021-2025 | Augment Injectable, Citrefix, Ortholoc 3di |
| Medical Device Business Services, INC. | $921.62 | 2019 | |
| Paragon 28, INC. | $886.50 | 2019 | |
| Kerecis Limited | $736.18 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $606.86 | 2023 | |
| Integra Lifesciences Corporation | $568.87 | 2019-2021 | |
| Smith+Nephew, INC. | $223.66 | 2022-2024 | Renasys Go V2 Home |
| Paratek Pharmaceuticals, INC. | $176.19 | 2022-2024 | Nuzyra |
| Eclipse Technology Solutions INC. | $147.90 | 2025 | |
| Osiris Therapeutics INC. | $122.28 | 2019 | |
| Depuy Synthes Sales INC. | $89.01 | 2019-2020 | |
| Biowound Solutions, INC. | $63.78 | 2025 | Bio-Connekt |
| Convatec INC. | $38.63 | 2024 | |
| Amgen INC. | $33.26 | 2024-2025 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $25.94 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chester Klimek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.